SLNO – soleno therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Soleno Therapeutics Announces VYKAT(TM) XR Launch [Yahoo! Finance]
Soleno Therapeutics Announces VYKAT(TM) XR Launch
Soleno Therapeutics, Inc. (NASDAQ: SLNO) was given a new $105.00 price target on by analysts at UBS Group AG.
Soleno Therapeutics, Inc. (NASDAQ: SLNO) had its price target raised by analysts at HC Wainwright from $70.00 to $100.00. They now have a "buy" rating on the stock.
Form 4 SOLENO THERAPEUTICS INC For: Apr 01 Filed by: Hirano Patricia C
Form 144 SOLENO THERAPEUTICS INC Filed by: Hirano Patricia C
Form SCHEDULE 13G/A SOLENO THERAPEUTICS INC Filed by: Vivo Opportunity Fund Holdings, L.P.
Form 4 SOLENO THERAPEUTICS INC For: Mar 28 Filed by: Pauls Matthew
Form 4 SOLENO THERAPEUTICS INC For: Mar 27 Filed by: Yen Kristen
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.